# TNYA (Tenaya Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Tenaya Therapeutics, Inc. reported $76.68M in total assets and a net loss of $101.8M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TNYA
- Markdown: https://convexityos.com/fundamentals/TNYA.md
- SEC CIK: 0001858848
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001858848&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$104.5M | Operating profit |
| Net Income | FY 2025 | -$101.8M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.45 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$54.65M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $66.80M | Total debt: $2.85M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $68.61M | $86.74M | $98.04M | $94.54M | $54.39M | $31.10M |
| Total Operating Expenses | $93.33M | $115.9M | $131.2M | $125.6M | $72.81M | $38.91M |
| **Operating Income** | -$93.33M | -$115.9M | -$131.2M | -$125.6M | -$72.81M | -$38.91M |
| **EBITDA** | -$84.89M | -$107.5M | -$122.5M | -$119.2M | -$69.84M | -$36.43M |
| Interest Income | $2.68M | $4.74M | $7.06M | $1.95M | $108K | $87K |
| Income Before Tax | -$90.60M | -$111.1M | -$124.1M | -$123.7M | -$72.72M | -$38.40M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$90.60M | -$111.1M | -$124.1M | -$123.7M | -$72.72M | -$38.40M |
| Basic EPS | -$0.59 | -$1.31 | -$1.68 | -$2.76 | -$4.10 | -$39.50 |
| **Diluted EPS** | -$0.59 | -$1.31 | -$1.68 | -$2.76 | -$4.10 | -$39.50 |
| Basic Shares Outstanding | 153.0M | 84.8M | 73.8M | 44.8M | 17.7M | 972.1K |
| Diluted Shares Outstanding | 153.0M | 84.8M | 73.8M | 44.8M | 17.7M | 972.1K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.70M | $1.11M | $225K | -- | -- | $0 | $0 | -- |
| Research & Development | $14.87M | $16.60M | $14.84M | $14.80M | $15.36M | $17.37M | $21.08M | $18.69M |
| Total Operating Expenses | $21.27M | $45.20M | $20.29M | $20.77M | $20.94M | $24.08M | $27.54M | $24.65M |
| **Operating Income** | -$19.57M | -$44.09M | -$20.07M | -$20.77M | -$20.94M | -$24.08M | -$27.54M | -$24.65M |
| **EBITDA** | -$19.18M | -$42.39M | -$18.30M | -$18.95M | -$19.07M | -$22.00M | -$24.88M | -$22.56M |
| Interest Income | $635K | $697K | $793K | $575K | $658K | $815K | $635K | $812K |
| Income Before Tax | -$18.94M | -$43.39M | -$19.27M | -$20.18M | -$20.27M | -$23.28M | -$26.86M | -$23.84M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$18.94M | -$43.39M | -$19.27M | -$20.18M | -$20.27M | -$23.28M | -$26.86M | -$23.84M |
| Basic EPS | -$0.08 | -$0.20 | -$0.09 | -- | -$0.12 | -$0.14 | -$0.24 | -- |
| **Diluted EPS** | -$0.08 | -$0.20 | -$0.09 | -- | -$0.12 | -$0.14 | -$0.24 | -- |
| Basic Shares Outstanding | 226.0M | 217.6M | 216.9M | -- | 163.3M | 162.8M | 109.9M | -- |
| Diluted Shares Outstanding | 226.0M | 217.6M | 216.9M | -- | 163.3M | 162.8M | 109.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $100.5M | $4.32M | $45.68M | $95.27M | $38.13M | $128.5M |
| Short-Term Investments | -- | $57.12M | $58.96M | $91.25M | $213.2M | -- |
| **Cash & Short-Term Investments** | $100.5M | $61.40M | $104.6M | $204.2M | $251.3M | $128.5M |
| Other Current Assets | $1.02M | $842K | $1.16M | $938K | -- | -- |
| **Total Current Assets** | $105.6M | $67.38M | $111.6M | $193.8M | $255.4M | $130.0M |
| Property, Plant & Equipment, Net | $27.67M | $35.86M | $43.28M | $51.03M | $43.02M | $17.18M |
| Long-Term Investments | -- | -- | -- | $17.70M | -- | -- |
| Other Non-Current Assets | $4.25M | $4.82M | $5.68M | $4.79M | $4.13M | $465K |
| **Total Non-Current Assets** | $41.34M | $52.56M | $58.93M | $85.19M | $58.83M | $18.20M |
| **Total Assets** | $146.9M | $119.9M | $170.5M | $278.9M | $314.2M | $148.2M |
| Accounts Payable | $3.58M | $5.16M | $5.63M | $9.58M | $10.72M | $1.02M |
| Other Current Liabilities | $176K | $214K | $478K | $545K | $162K | $121K |
| **Total Current Liabilities** | $15.44M | $15.97M | $22.73M | $24.25M | $21.77M | $5.04M |
| Other Non-Current Liabilities | $410K | $281K | $253K | $228K | $182K | $19K |
| **Total Non-Current Liabilities** | $8.22M | $11.11M | $8.36M | $11.32M | $13.89M | $3.68M |
| **Total Liabilities** | $23.66M | $27.09M | $31.09M | $35.57M | $35.66M | $8.72M |
| **Total Debt (incl. Leases)** | $10.83M | $13.61M | $12.42M | $15.10M | $15.70M | -- |
| Common Stock | $21K | $8.0K | $7.0K | $7.0K | $4.0K | -- |
| Retained Earnings | -$605.0M | -$514.4M | -$403.3M | -$279.2M | -$155.5M | -$82.81M |
| Accumulated Other Comp. Income | $0 | $28K | -$106K | -$378K | -$141K | -- |
| **Total Stockholders' Equity** | $123.3M | $92.85M | $139.4M | $243.4M | $278.5M | -$81.31M |
| Total Equity | $123.3M | $92.85M | $139.4M | $243.4M | $278.5M | -$81.31M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $66.80M | $78.08M | $80.89M | $100.5M | $56.31M | $62.67M | $53.77M | $4.32M |
| Short-Term Investments | -- | -- | -- | -- | -- | $9.00M | $34.39M | $57.12M |
| **Cash & Short-Term Investments** | $66.80M | $78.10M | $80.90M | $100.5M | $56.30M | $71.70M | $88.20M | $61.40M |
| Accounts Receivable, Net | $573K | $371K | $10.63M | -- | -- | -- | -- | -- |
| Other Current Assets | $185K | $4.07M | $25K | $1.02M | $990K | $218K | $1.23M | $842K |
| **Total Current Assets** | $71.01M | $86.01M | $96.56M | $105.6M | $61.24M | $75.88M | $94.48M | $67.38M |
| Property, Plant & Equipment, Net | $1.14M | $2.49M | $25.96M | $27.67M | $29.44M | $31.29M | $33.36M | $35.86M |
| Other Non-Current Assets | $2.06M | $2.07M | $3.79M | $4.25M | $4.24M | $4.31M | $4.81M | $4.82M |
| **Total Non-Current Assets** | $5.67M | $7.53M | $38.51M | $41.34M | $43.74M | $46.28M | $49.47M | $52.56M |
| **Total Assets** | $76.68M | $93.54M | $135.1M | $146.9M | $105.0M | $122.2M | $144.0M | $119.9M |
| Accounts Payable | $3.66M | $2.90M | $1.91M | $3.58M | $2.84M | $3.30M | $5.06M | $5.16M |
| Deferred Revenue (Current) | $5.66M | $5.73M | $5.72M | -- | -- | -- | -- | -- |
| Other Current Liabilities | $160K | $324K | $455K | $176K | $186K | $142K | $350K | $214K |
| **Total Current Liabilities** | $18.80M | $19.02M | $16.78M | $15.44M | $13.21M | $12.65M | $14.15M | $15.97M |
| Deferred Revenue (Non-Current) | $2.88M | $3.94M | $4.68M | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $52K | $103K | $418K | $410K | $301K | $293K | $287K | $281K |
| **Total Non-Current Liabilities** | $3.36M | $5.11M | $12.10M | $8.22M | $8.90M | $9.67M | $10.40M | $11.11M |
| **Total Liabilities** | $22.16M | $24.13M | $28.88M | $23.66M | $22.11M | $22.32M | $24.56M | $27.09M |
| **Total Debt (incl. Leases)** | $2.85M | $3.95M | $10.12M | $10.83M | $11.53M | $12.21M | $12.91M | $13.61M |
| Common Stock | $22K | $22K | $21K | $21K | $16K | $16K | $16K | $8.0K |
| Retained Earnings | -$686.6M | -$667.7M | -$624.3M | -$605.0M | -$584.8M | -$564.6M | -$541.3M | -$514.4M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | -- | -$1.0K | -$10K | $28K |
| **Total Stockholders' Equity** | $54.52M | $69.41M | $106.2M | $123.3M | $82.87M | $99.83M | $119.4M | $92.85M |
| Total Equity | $54.52M | $69.41M | $106.2M | $123.3M | $82.87M | $99.83M | $119.4M | $92.85M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$90.60M | -$111.1M | -$124.1M | -$123.7M | -$72.72M | -$38.40M |
| Depreciation & Amortization | $8.44M | $8.47M | $8.69M | $6.47M | $2.96M | $2.48M |
| Stock-Based Compensation | $13.05M | $16.50M | $15.31M | $11.47M | $2.95M | $741K |
| Change in Payables | -$1.43M | -$581K | -$3.28M | $1.66M | $8.60M | $142K |
| **Operating Cash Flow** | -$68.26M | -$90.50M | -$102.1M | -$104.4M | -$60.81M | -$35.45M |
| Capital Expenditure | -$618K | -$1.02M | -$1.24M | -$20.63M | -$25.12M | -$9.76M |
| **Free Cash Flow** | -$68.88M | -$91.53M | -$103.3M | -$125.1M | -$85.93M | -$45.21M |
| Purchases of Investments | $0 | -$87.07M | -$56.64M | -$140.5M | -$213.4M | -- |
| **Investing Cash Flow** | $56.08M | $1.13M | $48.72M | $83.65M | -$238.6M | -$7.01M |
| Common Stock Issued | -- | $46.76M | $3.87M | $77.39M | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -$13K | -$1.0K |
| **Financing Cash Flow** | $108.4M | $47.75M | $4.05M | $77.77M | $209.0M | $147.3M |
| **Net Change in Cash** | $96.22M | -$41.62M | -$49.31M | $56.99M | -$90.41M | $104.8M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18.94M | -$43.39M | -$19.27M | -$20.18M | -$20.27M | -$23.28M | -$26.86M | -$23.84M |
| Depreciation & Amortization | $394K | $1.70M | $1.76M | $1.83M | $1.86M | $2.08M | $2.66M | $2.09M |
| Stock-Based Compensation | $1.68M | $1.70M | $2.20M | $2.75M | $2.93M | $3.64M | $3.73M | $3.76M |
| Change in Receivables | -$17K | $10.26M | -$10.63M | -- | $0 | $0 | $0 | -- |
| Change in Payables | $758K | $988K | -$1.46M | $531K | -$447K | -$1.14M | -$379K | -$701K |
| **Operating Cash Flow** | -$17.68M | -$3.55M | -$19.23M | -$13.94M | -$15.60M | -$15.61M | -$23.11M | -$18.39M |
| Capital Expenditure | $0 | -$159K | -$11K | -$67K | -$26K | -$142K | -$383K | -$204K |
| **Free Cash Flow** | -$17.68M | -$3.71M | -$19.25M | -$14.01M | -$15.62M | -$15.76M | -$23.50M | -$18.59M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$2.01M |
| **Investing Cash Flow** | $26K | -$159K | -$11K | -$67K | $8.86M | $24.99M | $22.30M | $14.10M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $6.37M | $909K | -$415K | $58.24M | $380K | -$476K | $50.26M | $377K |
| **Net Change in Cash** | -$11.29M | -$2.80M | -$19.66M | $44.23M | -$6.36M | $8.90M | $49.45M | -$3.91M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -73.5% | -119.7% | -89.0% | -50.8% | -26.1% | -- |
| Return on Assets (ROA) | -61.7% | -92.7% | -72.8% | -44.3% | -23.1% | -25.9% |
| Current Ratio | 6.84x | 4.22x | 4.91x | 7.99x | 11.73x | 25.78x |
| Quick Ratio | 6.51x | 3.84x | 4.60x | 8.42x | 11.54x | 25.50x |
| Debt to Equity | 0.09x | 0.15x | 0.09x | 0.06x | 0.06x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -186.7% | -148.6% | -78.2% | -73.5% | -113.7% | -99.8% | -88.6% | -119.7% |
| Return on Assets (ROA) | -132.7% | -110.2% | -61.5% | -61.7% | -89.8% | -81.6% | -73.5% | -92.7% |
| Current Ratio | 3.78x | 4.52x | 5.75x | 6.84x | 4.64x | 6.00x | 6.68x | 4.22x |
| Quick Ratio | 3.58x | 4.13x | 5.45x | 6.51x | 4.26x | 5.67x | 6.23x | 3.84x |
| Debt to Equity | 0.05x | 0.06x | 0.10x | 0.09x | 0.14x | 0.12x | 0.11x | 0.15x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
